Debt-to-Equity Ratio

Amgen’s debt-to-equity ratio of 6.24x means the company uses $6.24 of debt for every $1 of shareholder equity, indicating a high reliance on borrowing to fund operations.

This is far above the healthcare sector median of 0.45x, placing Amgen in the 98th percentile among peers. Trend data is not available: the year-over-year change, quarter-over-quarter change, and last eight quarters are all listed as N/A. Without a trend, it is impossible to tell whether this extreme leverage is rising or falling, so the risk from high debt is unclear. The combination of a very high debt level and no directional information suggests caution but not an immediate red flag. This metric supports the overall NEUTRAL verdict because the elevated ratio signals potential financial risk, while the absence of trend data prevents a stronger bearish tilt.

Frequently Asked Questions

Closest Sector Peers